Physician profile
James D Bertus
NPI 1447357462
$4,468.45
in general payments reported to CMS, 2019-2025
25 companies · $77.42 in 2025
The $77.42 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $110 · 2021: $342 · 2022: $1,501 · 2023: $279 · 2024: $1,923 · 2025: $77.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,257 · Food and Beverage: $1,008 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,256.85 |
| Food and Beverage | $1,007.60 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $1,526.89 | 2024 | Sacroiliac Joint Fusion System |
| Spinal Simplicity, LLC | $1,246.02 | 2022 | |
| Abbott Laboratories | $321.92 | 2019-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $282.17 | 2019-2025 | General - Pain Management, Superion Indirect Decompression System |
| Abbvie INC. | $130.42 | 2021-2023 | Ubrelvy, Qulipta |
| Forte Bio-Pharma LLC | $119.18 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Si-Bone, INC. | $118.52 | 2022-2024 | |
| Saluda Medical Americas, INC. | $93.60 | 2024-2025 | Evoke |
| Vertex Pharmaceuticals Incorporated | $78.37 | 2024 | |
| Medtronic, INC. | $76.23 | 2021-2024 | Synchromedii, Intellis Adaptivestim |
| Daiichi Sankyo INC. | $71.86 | 2019 | |
| Pfizer INC. | $67.05 | 2020-2023 | |
| Biodelivery Sciences International, INC. | $65.26 | 2019-2021 | |
| Mml US, INC. | $51.10 | 2023-2025 | Reactiv8 |
| Allergan, INC. | $45.99 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $29.59 | 2023-2024 | Ztlido |
| Nevro Corp. | $24.08 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.61 | 2021 | |
| Conetic Solutions, INC. | $16.02 | 2021 | |
| Averitas Pharma INC. | $15.54 | 2024 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $15.18 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.58 | 2021 | |
| Lilly USA, LLC | $14.48 | 2022 | |
| Medtronic USA, INC. | $12.87 | 2019 | |
| Nalu Medical, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bertus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.